Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 52,352 shares at $14.74 ($771K) on 2023-08-03, disclosed to the SEC on 2023-08-04.
Scheduled sale ($771k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.09 | 9,280 | $140K | 18.2% |
| 2 | $15.09 | 9,280 | $140K | 18.2% |
| 3 | $16.01 | 1,000 | $16K | 2.1% |
| 4 | $16.82 | 68 | $1K | 0.1% |
| 5 | $14.74 | 9,464 | $139K | 18.1% |
| 6 | $14.74 | 9,464 |
| $139K |
| 18.1% |
| 7 | $14.14 | 6,898 | $98K | 12.6% |
| 8 | $14.14 | 6,898 | $98K | 12.6% |
| Total | $14.73 avg | 52,352 | $771K | 100% |
| Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |
| TRDA | SELL | 2022-10-27 | $537K | — | Filing → |